Appointment New Patient Appointment or 214-645-8300

Appointment New Patient Appointment or 214-645-8300

More Blogs

MedBlog

Raksha Jain, M.D.

Landmark cystic fibrosis clinical trial gives patients hope for healthy pregnancies

Landmark cystic fibrosis clinical trial gives patients hope for healthy pregnancies

TRIKAFTA may give patients with cystic fibrosis hope for healthy pregnancies. Learn about the landmark clinical trial to analyze its safety from pregnancy through two years after delivery.

Raksha Jain, M.D.

June 15, 2021

More men are dying from COVID-19 – hormones may be partly to blame

More men are dying from COVID-19 – hormones may be partly to blame

More men are dying from COVID-19, and testosterone may be part of the explanation. In this MedBlog, UT Southwestern discusses the underlying causes of men's risk factors.

Raksha Jain, M.D.

August 27, 2020

Cystic fibrosis breakthrough: 3-drug combo pill may benefit 90% of patients

Cystic fibrosis breakthrough: 3-drug combo pill may benefit 90% of patients

A new 3-drug combo drug for cystic fibrosis has been approved by the FDA. TRIKAFTA offers life-changing treatment potential for approximately 90% of patients with the disease. In this MedBlog, discover who is eligible and how the drug works. Learn more.

Raksha Jain, M.D.

March 6, 2020

Beyond the lungs: How CFTR modulators benefit cystic fibrosis patients

Beyond the lungs: How CFTR modulators benefit cystic fibrosis patients

Traditionally, patients with cystic fibrosis have been treated with inhaled medications that could affect the lungs with limited systemic effects. However, a relatively new set of drugs, CFTR modulators, offer an oral alternative with the potential to slow the progression of the disease for up to 90 percent of patients.

Raksha Jain, M.D.

May 24, 2018